Carcinogenesis

Carcinogenesis

致癌作用

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Carcinogenesis》是由Oxford University Press出版社于1980年创办的英文国际期刊(ISSN: 0143-3334,E-ISSN: 1460-2180),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.1255...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比93.02%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在86篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Carcinogenesis审稿周期约为 约1.0个月 。该刊近年未被列入国际预警名单,年发文量约86篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 86 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 118 / 322

63.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 91 / 322

71.89%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:9.2 SJR:1.074 SNIP:0.729
学科类别 分区 排名 百分位
大类:Biochemistry, Genetics and Molecular Biology 小类:Cancer Research Q2 61 / 230

73%

期刊发文

  • Molecular classification of IDH-mutant glioblastomas based on gene expression profiles.

    Author: Wu F1,2,3, Chai RC1,2,3, Wang Z1,2,3, Liu YQ1,2,3, Zhao Z1,2,3, Li GZ1,2,3, Jiang HY1,2,3.

    Journal: Carcinogenesis. 2019 Feb 13. pii: bgz032. doi: 10.1093/carcin/bgz032. [Epub ahead of print]

  • Oxytocin involves in chronic stress-evoked melanoma metastasis via β-arrestin 2-mediated ERK signaling pathway.

    Author: Ji H1, Liu N2, Li J3, Chen D4, Luo D5, Sun Q5, Yin Y3, Liu Y6, Bu B7, Chen X1, Li J5.

    Journal: Carcinogenesis. 2019 Mar 22. pii: bgz064. doi: 10.1093/carcin/bgz064. [Epub ahead of print]

  • Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.

    Author: Mo S1,2, Dai W1,2, Xiang W1,2, Li Y1,2, Feng Y1,2, Zhang L1,3, Li Q1,2, Cai G1,2.

    Journal: Carcinogenesis. 2019 Feb 19. pii: bgz031. doi: 10.1093/carcin/bgz031. [Epub ahead of print]

  • A deep learning model based on sparse auto-encoder for prioritizing cancer-related genes and drug target combinations.

    Author: Chang JW1,2, Ding Y1,2, Tahir Ul Qamar M1,2, Shen Y1, Gao J1, Chen LL1,2.

    Journal: Carcinogenesis. 2019 Apr 4. pii: bgz044. doi: 10.1093/carcin/bgz044. [Epub ahead of print]

  • ARHGAP4 regulates the cell migration and invasion of pancreatic cancer by the HDAC2/β-catenin signaling pathway.

    Author: Shen Y1,2, Xu L1,2, Ning Z1,2, Liu L1,2, Lin J1,2, Chen H1,2, Meng Z1,2.

    Journal: Carcinogenesis. 2019 Apr 8. pii: bgz067. doi: 10.1093/carcin/bgz067. [Epub ahead of print]

  • Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.

    Author: Luo D1,2,3, Fraga-Lauhirat M1, Millings J4, Ho C1, Villarreal EM1, Fletchinger TC1, Bonfiglio JV4, Mata L4, Nemesure MD4, Bartels LE4, Wang R4, Rigas B5,6, Mackenzie GG1,4.

    Journal: Carcinogenesis. 2019 Apr 17. pii: bgz069. doi: 10.1093/carcin/bgz069. [Epub ahead of print]

  • circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression.

    Author: Zou Y1, Zheng S1, Xiao W1, Xie X1, Yang A1, Gao G1, Xiong Z1, Xue Z1, Tang H1, Xie X1.

    Journal: Carcinogenesis. 2019 Apr 17. pii: bgz071. doi: 10.1093/carcin/bgz071. [Epub ahead of print]

  • Circulating obesity-driven biomarkers are associated with risk of clear cell renal cell carcinoma: a two-stage, case-control study.

    Author: Wang Q1,2, Tu H2, Zhu M2,3, Liang D4, Ye Y2,5, Chang DW2, Long Y2,6, Wu X2,5.

    Journal: Carcinogenesis. 2019 Apr 17. pii: bgz074. doi: 10.1093/carcin/bgz074. [Epub ahead of print]